First Financial Equity Corporation’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

First Financial Equity Corporation’s Portfolio EGRX Stock Details EGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$570K	Buy	+6,872	New	+$511K	0.1%	200

Other funds holding EGRX

PAI

ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

HEC

Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

First Financial Equity Corporation's EGRX Position: Q1 2017 in Review

First Financial Equity Corporation opened a new position in Eagle Pharmaceuticals, Inc. (EGRX) in Q1 2017: 6,872 shares worth $570K. The stake represents 0.1% of the portfolio and ranks #200 among its holdings.

147 funds tracked by Wall St. Rank hold EGRX as of Q1 2017.

First Financial Equity Corporation held 6,872 shares of Eagle Pharmaceuticals, Inc. worth $570K as of Q1 2017.
Eagle Pharmaceuticals, Inc. was a new First Financial Equity Corporation position in Q1 2017.
Eagle Pharmaceuticals, Inc. made up 0.1% of First Financial Equity Corporation's portfolio in Q1 2017, its #200 holding.
147 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q1 2017.

Based on First Financial Equity Corporation's 13F filing for Q1 2017, filed 16 May 2017.